Mira Pharmaceuticals (MIRA) Operating Expenses (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Operating Expenses of $5.8 million for Q4 2025, up 342.28% sequentially from $1.3 million in Q3 2025, and up 138.94% YoY from $2.4 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Operating Expenses (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals has reported Operating Expenses for 4 years, with the latest figure at $5.8 million in Q4 2025.
- Quarterly Operating Expenses rose 138.94% year-over-year to $5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (up 30.86% YoY) and the FY2025 annual result came in at $10.5 million, up 30.86% from the prior year.
- Operating Expenses climbed to $5.8 million in Q4 2025 per MIRA's latest filing, from $1.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $5.8 million in Q4 2025 and troughed at $970220.0 in Q2 2023.
- A 4-year average of $2.2 million and a median of $1.8 million in 2024 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 138.94% in 2025, down 36.73% in 2025.
- Over 4 years, Operating Expenses stood at $1.3 million in 2022, then jumped by 126.78% to $3.1 million in 2023, then slipped by 20.24% to $2.4 million in 2024, then soared by 138.94% to $5.8 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.8 million, $1.3 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 6.09 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 9.70 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -7.60 Bn |
| 10 | Mira Pharmaceuticals | 18.47 Mn | 7.44 Mn | - | 5.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 970,220.00 |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.81 Mn |